Volume 145, Issue 4, Pages 766-774.e1 (October 2013) Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease Julián Panés, Antonio López–SanRomán, Fernando Bermejo, Valle García–Sánchez, Maria Esteve, Yolanda Torres, Eugeni Domènech, Marta Piqueras, María Gomez–García, Ana Gutiérrez, Carlos Taxonera, Miquel Sans Gastroenterology Volume 145, Issue 4, Pages 766-774.e1 (October 2013) DOI: 10.1053/j.gastro.2013.06.009 Copyright © 2013 AGA Institute Terms and Conditions
Figure 1 Actuarial probability of survival free of relapse defined as a CDAI score >175 in patients treated with azathioprine and placebo. Gastroenterology 2013 145, 766-774.e1DOI: (10.1053/j.gastro.2013.06.009) Copyright © 2013 AGA Institute Terms and Conditions
Figure 2 Mean (A) CDAI and (B) IBDQ scores throughout the study in the groups treated with azathioprine (closed symbols) and placebo (open symbols). SDs of the mean are represented for each value. Gastroenterology 2013 145, 766-774.e1DOI: (10.1053/j.gastro.2013.06.009) Copyright © 2013 AGA Institute Terms and Conditions
Supplementary Figure 1 Enrollment and outcomes through week 76. Gastroenterology 2013 145, 766-774.e1DOI: (10.1053/j.gastro.2013.06.009) Copyright © 2013 AGA Institute Terms and Conditions